Stocks
Procter & Gamble Financial Statements (PG) |
||||||||||
| Procter & Gamblesmart-lab.ru | % | 2022 | 2023 | 2023 | 2024 | 2024 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 05.08.2022 | 30.06.2023 | 04.08.2023 | 30.06.2024 | 05.08.2024 | 18.10.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 80 187 | 82 006 | 82 006 | 84 039 | 84 039 | 82 996 | |||
| Operating Income, bln rub | 17 813 | 18 134 | 18 134 | 19 886 | 18 545 | 17 966 | ||||
| EBITDA, bln rub | ? | 21 241 | 21 823 | 21 771 | 22 782 | 23 844 | 21 205 | |||
| Net profit, bln rub | ? | 14 742 | 14 653 | 14 653 | 14 879 | 14 879 | 13 987 | |||
| OCF, bln rub | ? | 16 723 | 16 848 | 16 848 | 19 847 | 19 846 | 21 143 | |||
| CAPEX, bln rub | ? | 3 156 | 3 062 | 3 062 | 3 322 | 3 322 | 3 356 | |||
| FCF, bln rub | ? | 13 567 | 13 786 | 13 786 | 16 525 | 16 524 | 17 787 | |||
| Dividend payout, bln rub | 8 770 | 8 999 | 8 999 | 9 312 | 9 312 | 9 628 | ||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 59.5% | 61.4% | 61.4% | 62.6% | 62.6% | 68.8% | ||||
| OPEX, bln rub | 20 217 | 21 112 | 21 112 | 23 305 | 24 894 | 24 058 | ||||
| Cost of production, bln rub | 42 157 | 42 760 | 42 760 | 40 848 | 40 600 | 40 972 | ||||
| R&D, bln rub | 2 000 | 0.000 | 2 000 | 0.000 | 2 000 | 2 000 | ||||
| Interest expenses, bln rub | 439.0 | 756.0 | 756.0 | 925.0 | 925.0 | 911.0 | ||||
| Assets, bln rub | 117 208 | 120 829 | 120 829 | 122 370 | 122 370 | 126 482 | ||||
| Net Assets, bln rub | ? | 46 589 | 47 065 | 46 777 | 50 559 | 50 287 | 51 840 | |||
| Debt, bln rub | 31 493 | 34 607 | 34 607 | 32 460 | 33 369 | 36 153 | ||||
| Cash, bln rub | 7 214 | 8 246 | 8 246 | 9 482 | 9 482 | 12 156 | ||||
| Net debt, bln rub | 24 279 | 26 361 | 26 361 | 22 978 | 23 887 | 23 997 | ||||
| Ordinary share price, rub | 143.8 | 151.7 | 151.7 | 164.9 | 164.9 | 151.4 | ||||
| Number of ordinary shares, mln | 2 410 | 2 414 | 2 368 | 2 472 | 2 360 | 2 356 | ||||
| Market cap, bln rub | 346 577 | 366 301 | 359 351 | 407 666 | 389 228 | 356 611 | ||||
| EV, bln rub | ? | 370 856 | 392 662 | 385 712 | 430 644 | 413 115 | 380 608 | |||
| Book value, bln rub | -16 790 | -17 377 | -17 665 | 10 256 | -12 063 | -11 184 | ||||
| EPS, rub | ? | 6.12 | 6.07 | 6.19 | 6.02 | 6.30 | 5.94 | |||
| FCF/share, rub | 5.63 | 5.71 | 5.82 | 6.69 | 7.00 | 7.55 | ||||
| BV/share, rub | -6.97 | -7.20 | -7.46 | 4.15 | -5.11 | -4.75 | ||||
| EBITDA margin, % | ? | 26.5% | 26.6% | 26.5% | 27.1% | 28.4% | 25.5% | |||
| Net margin, % | ? | 18.4% | 17.9% | 17.9% | 17.7% | 17.7% | 16.9% | |||
| FCF yield, % | ? | 3.91% | 3.76% | 3.84% | 4.05% | 4.25% | 4.99% | |||
| ROE, % | ? | 31.6% | 31.1% | 31.3% | 29.4% | 29.6% | 27.0% | |||
| ROA, % | ? | 12.6% | 12.1% | 12.1% | 12.2% | 12.2% | 11.1% | |||
| P/E | ? | 23.5 | 25.0 | 24.5 | 27.4 | 26.2 | 25.5 | |||
| P/FCF | 25.5 | 26.6 | 26.1 | 24.7 | 23.6 | 20.0 | ||||
| P/S | ? | 4.32 | 4.47 | 4.38 | 4.85 | 4.63 | 4.30 | |||
| P/BV | ? | -20.6 | -21.1 | -20.3 | 39.7 | -32.3 | -31.9 | |||
| EV/EBITDA | ? | 17.5 | 18.0 | 17.7 | 18.9 | 17.3 | 17.9 | |||
| Debt/EBITDA | 1.14 | 1.21 | 1.21 | 1.01 | 1.00 | 1.13 | ||||
| R&D/CAPEX, % | 63.4% | 0.00% | 65.3% | 0.00% | 60.2% | 59.6% | ||||
| CAPEX/Revenue, % | 3.94% | 3.73% | 3.73% | 3.95% | 3.95% | 4.04% | ||||
| Procter & Gamble shareholders | ||||||||||
